Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 2 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 2 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19 ...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 18 hours agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine, becoming the second state attorney general ...
Gateway - Quartz
Quartz· 10 hours agoThe US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The move marks a major investment in the country even as relations ...
Kansas AG sues Pfizer over 'misleading' COVID-19 vaccine claims
FOX 23 Maine· 2 days agoKansas Attorney General Kris Kobach announced Monday he is suing pharmaceutical giant Pfizer for...
Pentagon defends anti-vaccine disinformation program in the Philippines
Task & Purpose· 4 days agoThe Department of Defense is standing by a major disinformation campaign it led that worked to...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 20 hours agoFood and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy...
Gateway - The Root
The Root· 2 days agoThe Biden administration is expected to announce this week that Americans who got the Pfizer-BioNTech or Moderna vaccines will need the third shot to protect ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Moderna stock is lone omen of bird flu pandemic
Reuters· 2 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
